Prenatal biochemical screening
- PMID: 1380558
Prenatal biochemical screening
Abstract
Most fetal abnormalities occur in low-risk pregnancies. Screening techniques have been developed to help determine who in the low-risk group may actually be at high risk. Biochemical screening for chromosomal abnormalities and neutral tube defects have significantly increased their detection, but there is still considerable room for improvement.
Similar articles
-
Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.J Matern Fetal Med. 1996 Mar-Apr;5(2):70-3. doi: 10.1002/(SICI)1520-6661(199603/04)5:2<70::AID-MFM4>3.0.CO;2-N. J Matern Fetal Med. 1996. PMID: 8796771
-
Maternal serum screening.Can Fam Physician. 1994 Oct;40:1756-64. Can Fam Physician. 1994. PMID: 7524838 Free PMC article.
-
[The use of the screening of maternal serum factors for the prenatal diagnosis of fetal developmental defects and chromosomal diseases].Tsitol Genet. 1995 Jul-Aug;29(4):44-7. Tsitol Genet. 1995. PMID: 8604526 Russian.
-
[Maternal serum screening for detection of fetal chromosome abnormalities].Gynakologe. 1995 Oct;28(5):280-8. Gynakologe. 1995. PMID: 7498824 Review. German. No abstract available.
-
Down syndrome: prenatal risk assessment and diagnosis.Am Fam Physician. 2000 Aug 15;62(4):825-32, 837-8. Am Fam Physician. 2000. PMID: 10969860 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical